Profile: iCell Therapeutics Inc. is a biotechnology company dedicated to offer new standards of care in oncology and cardiovascular treatments. Our site selective low density emulsion technology is validated by extensive pre-clinical animal & clinical studies, and these studies have generated an array of new product candidates for cancer & cardiovascular diseases. Our LDE is used to formulate new therapeutic agents applied to the treatment of subset of populations with tumors over-expressing LDL receptors.